Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03467854 · ClinicalTrials.gov registry record
PK of Piperacillin/Tazobactam in Adults Undergoing ECMO
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03467854: Clinical Trial study, sponsored by Columbia University.
NCT03467854 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03467854 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This study is designed to provide preliminary data to determine if concentrations of piperacillin/tazobactam change in patients with severe respiratory failure receiving extracorporeal membrane oxygenation (ECMO). The investigators hypothesize that patients will have significant changes in concentration measurements, specifically an increased clearance rate and increased volume of distribution, during ECMO as compared to critically ill patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2024-09-24 |
Why NCT03467854 stopped before completion
NCT03467854 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03467854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03467854 about?
NCT03467854 is a clinical study titled "PK of Piperacillin/Tazobactam in Adults Undergoing ECMO". This study is designed to provide preliminary data to determine if concentrations of piperacillin/tazobactam change in patients with severe respiratory failure receiving extracorporeal membrane oxygenation (ECMO). The investigators hypothesize that patients will have significant changes in concentra...
What is the current status of trial NCT03467854?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2019-01-01. Estimated completion is 2024-09-24.
Who is sponsoring clinical trial NCT03467854?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI